Languages
Pages
Legal
Explore all categories to find your favorite topic
ANRV281-BE08-05 ARI 12 June 2006 17:11 Drug-Eluting Bioresorbable Stents for Various Applications Meital Zilberman1 and Robert C Eberhart23 1Department of Biomedical Engineering…
Slide 1A Prospective, Randomized, "All-Comers" Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting…
Accepted to DOI: 10.1002/adma. 201300226 (Published online March 14th, 2013) Zinc Exhibits Ideal Physiological Corrosion Behavior for Bioabsorbable Stents By Patrick K. Bowen*,…
DRUG ELUTING STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: Reappraisal of the evidence Frank Van den Branden, MD Antwerp Cardiovascular Institute Middelheim Antwerp, Belgium…
Maurice Buchbinder, MD Foundation for Cardiovascular Medicine Biodegradable Stents Biodegradable Stents Maurice Buchbinder, MD Foundation for Cardiovascular Medicine La Jolla,…
Slide 1Late Results from the PAINT trial PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for the treatment…
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus Rasmussen,…
Sponsored by Boston Scientific Corporation Volume 5, No. 6 Michael Jaff, MD Gunnar Tepe, MD Hans van Overhagen, MD Theodosios Bisdas, MD J.A. Mustapha, MD Fadi Saab, MD Dierk…
Slide 1A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction – One Year…
Slide 1A Prospective, Randomized Comparison of Paclitaxel- eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction – One Year…
Abbott Russia Citizenship Report 2012-2013 Citizenship RepoRt 2013: ABBott in RUssiA Abbott is a diverse global healthcare company with scientific expertise and products…
Slide 1SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus…
Slide 1 A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With Coronary In-Stent Restenosis of Drug- Eluting Stents:…
Slide 1Upendra Kaul, MD for the TUXEDO INDIA Investigators Paclitaxel Eluting Versus Everolimus Eluting Stents in Patients with Diabetes Mellitus and Coronary Artery Disease…
Development of a probucol-releasing antithrombogenic drug eluting stent Kumar Vedantham,1* Somali Chaterji,2*† Sung Won Kim,1 Kinam Park1,2 1Department of Industrial and…
An apple a day Drug-eluting stents NICE to have you back in the real world! C. Diffi cile – the new hospital superbug Technology and using it to your advantage Glossary…
Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized DELAYED RRISC Trial Pierfrancesco…
Pulse of the industry Medical technology report 2010 Medtech innovation has often been driven by iterative changes to existing technologies As a result the industry’s business…
Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review Policies submitted without this form will…
New generation DES: which role in ACS?METCARDIO, Ospedaletti, Italy www.metcardio.org Why could drug-eluting stents possibly be safer than bare-metal stents? The case for